Title : Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling.

Pub. Date : 2021 Feb

PMID : 32940862






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERbeta and IL-6/gp130/STAT3 signaling. Raloxifene Hydrochloride estrogen receptor 1 Homo sapiens
2 Here, we hypothesized that raloxifene, a FDA-approved selective ER modulator (SERM), may suppress PDAC tumor growth by interfering with ERbeta signaling. Raloxifene Hydrochloride estrogen receptor 1 Homo sapiens
3 Our results suggest that ERbeta signaling and IL-6/gp130 interaction may serve as promising drug targets for pancreatic cancer and that raloxifene may serve as an attractive therapeutic option for PDAC patients expressing the ERbeta isotype. Raloxifene Hydrochloride estrogen receptor 1 Homo sapiens